Remicade trough levels 2 weeks after infusion were significantly lower in patients with acute severe ulcerative colitis vs. patients with moderately severe ulcerative colitis, according to the results ...

ORLANDO – Maintenance doses of the biologic agent infliximab (Remicade) can be safely administered at a patient's home with a very low rate of adverse events (AEs) and serious AEs, a researcher ...

If you have a certain type of arthritis or disease that causes inflammation, your doctor may recommend Remicade. It’s a prescription drug used in certain situations to treat: Remicade contains the ...

Remicade (infliximab) is a prescription drug that’s used to treat certain autoimmune conditions, such as rheumatoid arthritis. Remicade can cause side effects that range from mild to serious. Examples ...

Birmingham, UK - Although infliximab (Remicade, Centocor) was licensed for use in the treatment of ankylosing spondylitis (AS) in Europe nearly 2 years ago, in the UK there has been little experience ...

Infliximab is medicine used for many inflammatory or immune problems, such as certain types of arthritis, gut conditions, and skin conditions. Common side effects include infections, headache, or ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Following the implementation of standardized protocols ...

HORSHAM, PA and KENILWORTH, NJ, NOVEMBER 6, 2007—Centocor, Inc., Schering-Plough Corporation, and Mitsubishi Tanabe Pharma Corporation announced today that an estimated one million patients have now ...

LAS VEGAS, Nev., October 23, 2006 -- Patients with ulcerative colitis (UC) treated with REMICADE® (infliximab) had an approximate 50 percent reduction in mean number of hospitalizations per year ...

Therapeutic persistence with infliximab was associated with signifi cantly fewer ulcerative colitis patients requiring hospitalization; once hospitalized, patients with therapeutic persistence had ...